| P2093 | author name string | Necmettin Akdeniz | |
| | Melek Aslan Kayiran | |
| P2860 | cites work | Histamine H2-receptor antagonists for urticaria | Q24201100 |
| | A practical guide to anaphylaxis | Q28211058 |
| | A consensus parameter for the evaluation and management of angioedema in the emergency department. | Q33909577 |
| | Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. | Q34035726 |
| | Clinical practice. Chronic urticaria and angioedema | Q34498368 |
| | Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine | Q34574061 |
| | Management of chronic urticaria in Asia: 2010 AADV consensus guidelines | Q35937122 |
| | Diagnosis and treatment of urticaria and angioedema: a worldwide perspective | Q36834774 |
| | Use of antihistamines in pediatrics. | Q37069153 |
| | Evidence-based diagnosis and treatment of chronic urticaria/angioedema | Q38179103 |
| | The diagnosis and management of acute and chronic urticaria: 2014 update. | Q38207184 |
| | Chronic urticaria as a systemic disease | Q38207220 |
| | The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update | Q38208428 |
| | Antihistamine use in children | Q38242172 |
| | Clinical features of adolescents with chronic idiopathic or spontaneous urticaria: Review of omalizumab clinical trials. | Q38378350 |
| | Clinical management of urticaria using omalizumab: the first licensed biological therapy available for chronic spontaneous urticaria | Q38861332 |
| | Management of chronic spontaneous urticaria in routine clinical practice: A Delphi-method questionnaire among specialists to test agreement with current European guidelines statements | Q39059966 |
| | The pathogenesis of chronic idiopathic urticaria | Q40885850 |
| | Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation | Q41914191 |
| | Chronic Spontaneous Urticaria: Pathogenesis and Treatment Considerations | Q42736757 |
| | Experience with cyclosporine in children with chronic idiopathic urticaria | Q43290172 |
| | Prevalence of sensitivity to food and drug additives in patients with chronic idiopathic urticaria | Q43743804 |
| | The Xolair Pregnancy Registry (EXPECT): the safety of omalizumab use during pregnancy | Q44503255 |
| | Pseudoallergic reactions in chronic urticaria are associated with altered gastroduodenal permeability | Q45050087 |
| | High prevalence of mental disorders and emotional distress in patients with chronic spontaneous urticaria | Q48666224 |
| | Retreatment with omalizumab results in rapid remission in chronic spontaneous and inducible urticaria. | Q50727804 |
| | [Urticaria in children attending allergy services]. | Q52774120 |
| | Acute urticaria in infancy and early childhood: a prospective study | Q74375479 |
| | Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial | Q79162159 |
| | Urticaria | Q80984630 |
| P433 | issue | 1 | |
| P921 | main subject | urticaria | Q187440 |
| P304 | page(s) | 93-99 | |
| P577 | publication date | 2019-02-14 | |
| P1433 | published in | İstanbul Kuzey Klinikleri | Q50810699 |
| P1476 | title | Diagnosis and treatment of urticaria in primary care. | |
| P478 | volume | 6 | |